Laman UtamaONC • TSE
add
Oncolytics Biotech Inc
Tutup sebelumnya
$1.25
Julat hari
$1.18 - $1.25
Julat tahun
$1.02 - $2.08
Permodalan pasaran
93.26J CAD
Bilangan Purata
158.96K
Nisbah P/E
-
Hasil dividen
-
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (CAD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Hasil | — | — |
Perbelanjaan pengendalian | 9.90J | -10.40% |
Pendapatan bersih | -9.54J | 3.85% |
Margin untung bersih | — | — |
Pendapatan bagi setiap syer | -0.12 | 10.29% |
EBITDA | -9.86J | 10.56% |
Kadar cukai berkesan | -0.13% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (CAD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 19.60J | -50.98% |
Jumlah aset | 24.26J | -47.36% |
Jumlah liabiliti | 15.20J | -10.93% |
Jumlah ekuiti | 9.06J | — |
Syer tertunggak | 77.07J | — |
Harga kepada buku | 10.42 | — |
Pulangan pada aset | -87.86% | — |
Pulangan pada modal | -167.51% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (CAD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -9.54J | 3.85% |
Tunai daripada operasi | -4.83J | 19.87% |
Tunai daripada pelaburan | -32.00K | -100.47% |
Tunai daripada pembiayaan | -173.00K | -100.81% |
Perubahan bersih dalam tunai | -5.25J | -123.38% |
Aliran tunai bebas | -1.70J | -171.09% |
Perihal
Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that: induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
Diasaskan
1998
Ibu pejabat
Tapak web
Pekerja
29
